Dexamethasone Shows Potential Of Repurposed Generics Against COVID-19

Repurposing Existing Medicines Is Key Part Of Pandemic Solution, Industry Insists

Positive trial results for dexamethasone in treating COVID-19 patients demonstrate the potential of repurposing existing generic medicines to fight the coronavirus pandemic.

Dexamethasone
DEXAMETHASONE HAS Seen POSITIVE TRIAL RESULTS IN COVID-19 PATIENTS • Source: Shutterstock

More from Generics

More from Biosimilars & Generics